Newsfeeds Archive - Page 226 of 236

1 minute read

Ecolab’s Margin Momentum Amid Headwinds: Analyst Raises Price Target And Expects Easing Price/Cost Trends

Yesterday, 3:28 PM

Mizuho analyst Christopher Parkinson reiterated a Neutral rating on the shares of Ecolab Inc. (NYSE:ECL), raising the price target to $177 from…

ECL

1 minute read

Healthcare Solutions Trends And M&A Prospects: AmerisourceBergen Gets A Price Target Hike Amid Upside Scenarios

By Nabaparna Bhattacharya

Yesterday, 3:17 PM

Mizuho analyst Ann Hynes reiterated a Neutral rating on the shares of AmerisourceBergen Corporation (NYSE:ABC), raising the price target to $174…

ABC

1 minute read

Neurocrine Biosciences Clocks 35% Revenue Growth In Q1, Misses On Bottom-Line Performance

By Nabaparna Bhattacharya

Yesterday, 2:26 PM

Neurocrine Biosciences Inc (NBIX) reported first-quarter FY23 sales of $420.40 million, up 35.4% year over year, beating the consensus of…

NBIX

1 minute read

Malibu Boats Q3 Earnings Exceed Expectations On Higher Unit Volumes, Plans Capacity Expansion

By Nabaparna Bhattacharya

Yesterday, 1:59 PM

Malibu Boats Inc (NASDAQ:MBUU) reported third-quarter FY23 sales growth of 9% year-on-year, to $375.12 million, beating the analyst consensus of…

MBUU

1 minute read

Louisiana-Pacific Q1; EPS Beat, 50% Revenue Slump, Lower Volume & More

By Nabaparna Bhattacharya

Yesterday, 1:35 PM

Louisiana-Pacific Corp (NYSE: LPX) reported a first-quarter FY23 sales decline of 50% year-on-year to $584 million, missing the consensus of $621.34…

LPX

1 minute read

HanesBrands Clocks 12% Decline In Q1 Revenues On Lower Consumer Spending

By Nabaparna Bhattacharya

Yesterday, 12:02 PM

HanesBrands Inc (NYSE:HBI) reported a first-quarter FY23 sales decline of 12% year-on-year to $1.39 billion, beating the consensus of $1.36…

HBI

1 minute read

Merger-Bound Horizon Therapeutics’ Q1 Earnings Miss Estimates

By Nabaparna Bhattacharya

Yesterday, 11:51 AM

Horizon Therapeutics (NASDAQ:HZNP) reported first-quarter FY23 sales of $832.06 million, down 6% year over year, missing the consensus of $902.28…

HZNP

1 minute read

BioCryst Clocks 37.8% Revenue Growth In Q1 On Solid New Patient Growth

By Nabaparna Bhattacharya

Yesterday, 10:57 AM

BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) reported first-quarter FY23 revenues of $68.78 million, up 37.8% year over year. The revenues missed the…

BCRX

2 minute read

Ingredion Raises Outlook After Q1 Earnings Beat, Expects Greater Customer Demand

By Nabaparna Bhattacharya

Yesterday, 10:29 AM

Ingredion Inc (NYSE: INGR) reported first-quarter FY23 sales growth of 13% year-on-year to $2.14 billion,

INGR

1 minute read

Bunge Q1 Earnings Top Expectations Amid Fluctuations In Global Supplies And Consumer Behavior

By Nabaparna Bhattacharya

Yesterday, 7:28 AM

Bunge Ltd (NYSE:BG) reported a first-quarter FY23 sales decline of 3.5% year-on-year to $15.33 billion, beating the consensus of $14.78…